Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?

Perez RO, Habr-Gama A, São Julião GP, Vailati BB, Fernandez LM, Gama-Rodrigues J, Camargo AA.

Dis Colon Rectum. 2016 Sep;59(9):895-7. doi: 10.1097/DCR.0000000000000620. No abstract available.

PMID:
27505119
2.

Intratumoral Genetic Heterogeneity in Rectal Cancer: Are Single Biopsies representative of the entirety of the tumor?

Bettoni F, Masotti C, Habr-Gama A, Correa BR, Gama-Rodrigues J, Vianna MR, Vailati BB, São Julião GP, Fernandez LM, Galante PA, Camargo AA, Perez RO.

Ann Surg. 2016 Jul 29. [Epub ahead of print]

PMID:
27479130
3.

Facilitating a culture of responsible and effective sharing of cancer genome data.

Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, Liao RG, Andre F, Banks I, Barrett JC, Caldas C, Camargo AA, Fitzgerald RC, Mao M, Mattison JE, Pao W, Sellers WR, Sullivan P, Teh BT, Ward RL, ZenKlusen JC, Sawyers CL, Voest EE.

Nat Med. 2016 May 5;22(5):464-71. doi: 10.1038/nm.4089.

PMID:
27149219
4.

Light/Dark Environmental Cycle Imposes a Daily Profile in the Expression of microRNAs in Rat CD133(+) Cells.

Marçola M, Lopes-Ramos CM, Pereira EP, Cecon E, Fernandes PA, Tamura EK, Camargo AA, Parmigiani RB, Markus RP.

J Cell Physiol. 2016 Sep;231(9):1953-63. doi: 10.1002/jcp.25300. Epub 2016 Jan 14.

PMID:
26728119
5.

The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.

Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PA, Perez RO, Camargo AA.

Oncotarget. 2015 Nov 10;6(35):38360-71. doi: 10.18632/oncotarget.5256.

6.

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice.

Campesato LF, Barroso-Sousa R, Jimenez L, Correa BR, Sabbaga J, Hoff PM, Reis LF, Galante PA, Camargo AA.

Oncotarget. 2015 Oct 27;6(33):34221-7. doi: 10.18632/oncotarget.5950.

7.

Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.

Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim AC, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PA, Camargo AA.

Cancer Genet. 2015 Jun;208(6):319-26. doi: 10.1016/j.cancergen.2015.03.010. Epub 2015 Mar 25.

PMID:
25963525
8.

Alternative polyadenylation allows differential negative feedback of human miRNA miR-579 on its host gene ZFR.

Hinske LC, Galante PA, Limbeck E, Möhnle P, Parmigiani RB, Ohno-Machado L, Camargo AA, Kreth S.

PLoS One. 2015 Mar 23;10(3):e0121507. doi: 10.1371/journal.pone.0121507. eCollection 2015.

9.

ICRmax: an optimized approach to detect tumor-specific interchromosomal rearrangements for clinical application.

Donnard ER, Carpinetti PA, Navarro FC, Perez RO, Habr-Gama A, Parmigiani RB, Camargo AA, Galante PA.

Genomics. 2015 May;105(5-6):265-72. doi: 10.1016/j.ygeno.2015.01.009. Epub 2015 Feb 7.

10.

Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.

Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB.

BMC Med Genomics. 2014 Dec 11;7:68. doi: 10.1186/s12920-014-0068-7.

11.

Expiratory Reserve Volume During Slow Expiration With Glottis Opened in Infralateral Decubitus Position (ELTGOL) in Chronic Pulmonary Disease: Technique Description and Reproducibility.

Lanza FC, Alves CS, dos Santos RL, de Camargo AA, Dal Corso S.

Respir Care. 2015 Mar;60(3):406-11. doi: 10.4187/respcare.03384. Epub 2014 Dec 9.

12.

Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell lines.

Pereira IT, Ramos EA, Costa ET, Camargo AA, Manica GC, Klassen LM, Chequin A, Braun-Prado K, Pedrosa Fde O, Souza EM, Costa FF, Klassen G.

PLoS One. 2014 Sep 10;9(9):e105806. doi: 10.1371/journal.pone.0105806. eCollection 2014.

13.

Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.

Donnard E, Asprino PF, Correa BR, Bettoni F, Koyama FC, Navarro FC, Perez RO, Mariadason J, Sieber OM, Strausberg RL, Simpson AJ, Jardim DL, Reis LF, Parmigiani RB, Galante PA, Camargo AA.

Oncotarget. 2014 Oct 15;5(19):9199-213.

14.

Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals.

Costa ET, Barnabé GF, Li M, Dias AA, Machado TR, Asprino PF, Cavalher FP, Ferreira EN, Del Mar Inda M, Nagai MH, Malnic B, Duarte ML, Leite KR, de Barros AC, Carraro DM, Chammas R, Armelin HA, Cavenee W, Furnari F, Camargo AA.

Oncogene. 2015 Mar 5;34(10):1270-9. doi: 10.1038/onc.2014.70. Epub 2014 Mar 24.

PMID:
24662834
15.

Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.

Machado CM, Andrade LN, Teixeira VR, Costa FF, Melo CM, dos Santos SN, Nonogaki S, Liu FT, Bernardes ES, Camargo AA, Chammas R.

Cancer Med. 2014 Apr;3(2):201-14. doi: 10.1002/cam4.173. Epub 2014 Jan 12.

16.

Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis.

de Camargo AA, Amaral TS, Rached SZ, Athanazio RA, Lanza FC, Sampaio LM, de Carvalho CR, Cukier A, Stelmach R, Dal Corso S.

Arch Phys Med Rehabil. 2014 May;95(5):892-9. doi: 10.1016/j.apmr.2013.11.019. Epub 2013 Dec 17.

PMID:
24361325
17.

The human cell surfaceome of breast tumors.

da Cunha JP, Galante PA, de Souza JE, Pieprzyk M, Carraro DM, Old LJ, Camargo AA, de Souza SJ.

Biomed Res Int. 2013;2013:976816. doi: 10.1155/2013/976816. Epub 2013 Sep 9.

18.

Reproducibility of step tests in patients with bronchiectasis.

Camargo AA, Lanza FC, Tupinambá T, Corso SD.

Braz J Phys Ther. 2013 May-Jun;17(3):255-62.

19.

Reference equation for the 2-minute walk test in adults and the elderly.

Selman JP, de Camargo AA, Santos J, Lanza FC, Dal Corso S.

Respir Care. 2014 Apr;59(4):525-30. doi: 10.4187/respcare.02649. Epub 2013 Aug 6.

20.

A symptom-limited incremental step test determines maximum physiological responses in patients with chronic obstructive pulmonary disease.

Dal Corso S, de Camargo AA, Izbicki M, Malaguti C, Nery LE.

Respir Med. 2013 Dec;107(12):1993-9. doi: 10.1016/j.rmed.2013.06.013. Epub 2013 Jul 14.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk